Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Schrödinger and SPARC announce Collaboration to accelerate Neurodegeneration Drug Development Program

Posted On: 2018-12-03 08:24:43

Schrödinger and Sun Pharma Advanced Research Company Ltd. (SPARC) (Reuters: SPRC.BO, Bloomberg: SPADV IN, NSE: SPARC, BSE: 532872) today announced a research collaboration to accelerate the discovery of novel CNS therapeutics by leveraging Schrödinger's advanced computational platform and SPARC's extensive drug development expertise and insights in neurodegeneration.

Schrödinger, a privately held company committed to revolutionizing drug discovery through advanced molecular simulation, will focus on lead discovery and optimization. SPARC, a clinical-stage company focused on improving patient care through innovation, will be responsible for compound synthesis and assays.

"This research collaboration is particularly exciting because neurodegeneration is an area where we urgently need more options for patients through novel approaches to drug discovery and development," said Ramy Farid, Ph.D., president and CEO of Schrödinger. "SPARC has been working with leading academic researchers to explore pathways relevant to disorders of the central nervous system, and their insights are quite compelling. Teaming up will allow us to rapidly interrogate therapeutic compounds that target these pathways."

"We have used Schrödinger's software for years and have experienced directly the power of their physics-based approaches to computational modeling, so we're delighted to form a collaboration that lets us tap into the expertise of their drug discovery team as well," said Anil Raghavan, CEO of SPARC. "At SPARC, we're committed to fueling innovation through both internal R&D and strategic partnerships with industry leaders, and this collaboration is a strong step in that direction. By working together, we can greatly accelerate the pace of innovation."

Shares of SUN PHARMA ADVANCED RESEARCH COMPANY LTD. was last trading in BSE at Rs.258.75 as compared to the previous close of Rs. 251.75. The total number of shares traded during the day was 55078 in over 1249 trades.

The stock hit an intraday high of Rs. 261.3 and intraday low of 251. The net turnover during the day was Rs. 14218378.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

IFCI Ltd reports loss of Rs. 16.55 crores in Q2 FY19

Muthoot Finance Ltd Q2 FY19 PAT climbs to Rs. 483.83 crores

IndiGo brings its school adoption programme to Vadodara; adopts 15 government schools

WhizAI raises $1.1 Million in Seed Funding Led by Trigyn Technologies, Inc.

ETT Ltd appoints director

Power Grid declared as successful bidder under TBCB

Sagar Cements Ltd approves new projects

Avenue Supermarts Ltd issues Commercial Paper of Rs. 100 crore

UROS Group joins forces with Tata Communications to accelerate IoT and Smart City projects

ICICI Bank Ltd announces change of Government Nominee Director

Nestle India Limited Board approves Dividend of Rs. 50

Ravalgaon Sugar Farm Ltd approves sale of land, machinery

Spice Mobility Ltd announces resignation of CFO

Indian Hume Pipe Company Ltd receives LoA for work of Rs. 204.51 crores

Lemon Tree Hotels Ltd opens new hotel at Connaught Road, Pune

Mr Milan Paleja to step down from Novartis India Ltd

Brickwork Ratings upgrades rating of Xpro India Ltd

Indo Gulf Industries Ltd announces change in CS

Tasty Dairy Specialties Ltd inks MoU with Foundation Dutch Greenhouse Delta

PVP Ventures Ltd appoints additional director

AARV Infratel Ltd enters into term sheet with Quess Corp

Maruti Suzuki India mulls price increase from January 2019

Capital India Finance Ltd board to consider rights issue

US FDA completes inspection of Lupin's Mandideep location

SEAMEC III commences 1 year charter with ONGC

Sri Amarnath Finance Ltd announces resignation of CS

Promoter announces offer for sale of shares of RattanIndia Infrastructure Ltd

L&T Construction wins orders valued Rs.2106 Crore

Alembic Pharmaceuticals receives USFDA Approval for Candesartan Cilexetil Tablets USP, 4 mg, 8 mg, and 16 mg.

Divya Jyoti Industries Limited announces resignation of CS

NTPC Wins 85 MW Solar Capacities in UPNEDA's 550 MW Solar Tender

SISL Board approves the scheme of amalgamation of Total Securities with the Company

Rural Electrification Corporation Ltd reports Q2 FY19 PAT of Rs. 1764.33 crores

IL&FS Investment Managers Ltd board to consider Q2 results on Dec 14, 2018

Opto Circuits India Ltd board to announce Q3 results on Feb 12, 2019

Oriental Aromatics Ltd fixes Dec 14, 2018 as record date for bonus issue, stock split

Bosch Ltd appoints Dr. Gopichand Katragadda as an Additional Director

ITC Savlon introduces Braille enabled Packs of antiseptic liquid

MY FM launches 5th edition of 'MY FM Rangrezz'

Gaurs Group gives exit to Indiabulls, pays Rs 340 crores debt

Allen Solly recreates innovative 'Open Work Culture' for Moviegoers

Jain Farm Fresh launches Valley Spice range

Capri Global Capital Limited appoints Mr. Ajay Kumar Relan as independent director

Veto Switchgears and Cables Ltd calls for board meeting on Dec 15, 2018

Alna Trading & Exports Ltd appoints CS

Mr. Rikenkumar Dalwadi appointed as compliance officer of EIMCO Elecon India Ltd

Kesoram Industries Ltd approves demerger of tyre business to Birla Tyres Ltd

The New India Assurance Company Ltd announces change in Chairman and MD

Trigyn Technologies Inc. declares dividend to Trigyn Technologies Limited

Kridhan Infra Ltd's associate company Vijay Nirman Company wins order worth INR 105 crores







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2018